Last reviewed · How we verify
Haloperidol Tablets, Cycle Pharmaceuticals Ltd — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Haloperidol Tablets, Cycle Pharmaceuticals Ltd (Haloperidol Tablets, Cycle Pharmaceuticals Ltd) — Cycle Pharmaceuticals Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Haloperidol Tablets, Cycle Pharmaceuticals Ltd TARGET | Haloperidol Tablets, Cycle Pharmaceuticals Ltd | Cycle Pharmaceuticals Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Haloperidol Tablets, Cycle Pharmaceuticals Ltd CI watch — RSS
- Haloperidol Tablets, Cycle Pharmaceuticals Ltd CI watch — Atom
- Haloperidol Tablets, Cycle Pharmaceuticals Ltd CI watch — JSON
- Haloperidol Tablets, Cycle Pharmaceuticals Ltd alone — RSS
Cite this brief
Drug Landscape (2026). Haloperidol Tablets, Cycle Pharmaceuticals Ltd — Competitive Intelligence Brief. https://druglandscape.com/ci/haloperidol-tablets-cycle-pharmaceuticals-ltd. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing